Search

Leidos Posts Strong Third Quarter, Increases Earnings Guidance

Leidos Posts Strong Third Quarter, Increases Earnings Guidance
Leidos Chairman and CEO Roger Krone. Photo: Leidos

Leidos [LDOS] on Tuesday followed up a strong second quarter with still strong financial results for its third quarter and the company raised its earnings guidance for the year. Net income soared 28 percent to $208 million, $1.43 earnings per share (EPS), from $163 million ($1.13 EPS) a year ago. Excluding certain expenses, adjusting earnings of $1.80 EPS topped consensus estimates by 18 cents per share. Adjusted operating margin rose 90 basis points to 11.6 percent. Sales in the quarter…

Subscriber-only content. Please log in below.

Not a subscriber or registered user yet?

Please contact us at clientservices@accessintel.com or call us at 888-707-5814 (Monday – Thursday 9:00 a.m. – 5:30 p.m. and Friday 9:00 a.m. – 3:00 p.m. ET.), to start a free trial, get pricing information, order a reprint, or post an article link on your website.



Contract Updates

Intertrade Limited (Cedar Rapids, Iowa) – $9,272,637

Intertrade Limited, Cedar Rapids, Iowa, has been awarded a maximum $9,272,637 firm-fixed-price contract for F-16 generator controls. This was a sole-source acquisition using justification 10 U.S. Code 3204 (a)(1), as stated in Federal Acquisition Regulation 6.302-1. This is a four-year…


Cottonwood Inc. (Lawrence, Kansas) – $44,370,000

Cottonwood Inc.,** Lawrence, Kansas, has been awarded a maximum $44,370,000 firm-fixed-price, indefinite-quantity contract for aircraft cargo tie down straps. This was a sole-source acquisition using justification 10 U.S. Code 3204 (a)(5), as stated in Federal Acquisition Regulation 8.7. This is…


Teva Pharmaceuticals USA Inc. (Parsippany, New Jersey) – $46,087,497

Teva Pharmaceuticals USA Inc., Parsippany, New Jersey, has been awarded a maximum $46,087,497 modification (P00009) exercising the third one-year option period of a five-year base contract (SPE2DP-20-D-0002) with five one-year option periods for adenovirus type 4 and type 7 vaccines.…


Northrop Grumman Systems Corp. (Oklahoma City, Oklahoma) – $64,111,631

Northrop Grumman Systems Corp., Oklahoma City, Oklahoma, has been awarded an estimated $64,111,631 delivery order (SPRTA1-26-F-0034) and modification (P00015) to a four-year subsumable base contract (SPRTA1-19-D-0001) with one five-year option period for additional pricing for the manufacture and production of…